Compare Nephrocare Healt with Similar Stocks
Stock DNA
Healthcare Services
INR 5,493 Cr (Small Cap)
82.00
57
0.00%
-0.02
11.74%
9.57
Total Returns (Price + Dividend) 
Nephrocare Healt for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Announcement under Regulation 30 (LODR)-Change in Management
03-Apr-2026 | Source : BSEDesignation of Mr. Prashant Vinodkumar Goenka Chief Financial Officer as the Chief Risk Officer of the company w.e.f. April 03 2026 in addition to his existing responsibilities as per SEBI Listing Regulations.
Announcement Under Regulation 30 (LODR)- Disclosure Of Litigation Filed By The Company
02-Apr-2026 | Source : BSEPursuant to Regulation 30 of SEBI LODR 2015 this is to inform that the Company has filed a Writ Petition on April 02 2026 before Honble High Court of Jammu & Kashmir and Ladakh at Srinagar.
Closure of Trading Window
25-Mar-2026 | Source : BSETrading window shall be closed till 48 hours from the declaration of Audited Financial Results of the company for the quarter and year ended March 31 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 7 Schemes (3.1%)
Held by 20 FIIs (9.3%)
Edoras Investment Holdings Pte Ltd (28.3%)
Investcorp India Investments Holding Limited (6.29%)
5.92%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






